Molecular mechanism of L-SP40 peptide and in vivo efficacy against EV-A71 in neonatal mice

Lalani, Salima and Tan, Soon Hao and Tan, Kuan Onn and Lim, Hui Xuan and Ong, Kien Chai and Wong, Kum Thong and Poh, Chit Laa (2021) Molecular mechanism of L-SP40 peptide and in vivo efficacy against EV-A71 in neonatal mice. Life Sciences, 287. ISSN 0024-3205, DOI https://doi.org/10.1016/j.lfs.2021.120097.

Full text not available from this repository.

Abstract

Aims: Enterovirus A71 (EV-A71) is an etiological agent of hand foot and mouth disease (HFMD) and has the potential to cause severe neurological infections in children. L-SP40 peptide was previously known to inhibit EVA71 by prophylactic action. This study aimed to identify the mechanism of inhibition in Rhabdomyosarcoma (RD) cells and in vivo therapeutic potential of L-SP40 peptide in a murine model. Main methods: A pull-down assay was performed to identify the binding partner of the L-SP40 peptide. Coimmunoprecipitation and co-localization assays with the L-SP40 peptide were employed to confirm the receptor partner in RD cells. The outcomes were validated using receptor knockdown and antibody blocking assays. The L-SP40 peptide was further evaluated for the protection of neonatal mice against lethal challenge by mouseadapted EV-A71. Key findings: The L-SP40 peptide was found to interact and co-localize with nucleolin, the key attachment receptor of Enteroviruses A species, as demonstrated in the pull-down, co-immunoprecipitation and co-localization assays. Knockdown of nucleolin from RD cells led to a significant reduction of 3.5 logs of viral titer of EV-A71. The L-SP40 peptide demonstrated 80% protection of neonatal mice against lethal challenge by the mouseadapted virus with a drastic reduction in the viral loads in the blood (similar to 4.5 logs), skeletal muscles (1.5 logs) and brain stem (1.5 logs). Significance: L-SP40 peptide prevented severe hind limb paralysis and death in suckling mice and could serve as a potential broad-spectrum antiviral candidate to be further evaluated for safety and potency in future clinical trials against EV-A71.

Item Type: Article
Funders: Ministry of Higher Education, Malaysia under FRGS [FRGS/1/2018/SKK11/SYUC/03/3], [FRGS/1/2020/SKK06/SYUC/01/1], Centre for Virus and Vaccine Research, Sunway University
Uncontrolled Keywords: Enterovirus A71 (EV-A71); Hand foot and mouth disease (HFMD); Antiviral; In vivo protection; Nucleolin; L-SP40 peptide
Subjects: R Medicine > R Medicine (General)
Divisions: Faculty of Medicine > Pathology Department
Depositing User: Ms Zaharah Ramly
Date Deposited: 16 Aug 2022 08:18
Last Modified: 16 Aug 2022 08:18
URI: http://eprints.um.edu.my/id/eprint/28662

Actions (login required)

View Item View Item